Are You Ready to Complete Your Toxics Release Inventory Report?

| May 10, 2019

article image
This is the date most EHS managers like almost as much as Christmas: the end (usually) of the regulatory reporting season. But before we get a much-needed break, we need to ensure we have completed all the required reports, which includes the Toxics Release Inventory (TRI) mandated by the EPA. Like the Tier II report, the TRI reporting requirements were implemented in an effort to make the public aware of hazardous chemicals present in their communities. Are you prepared to complete and file your report by the deadline?

Spotlight

Seattle Genetics

Seattle Genetics is dedicated to improving patient outcomes through advanced antibody-drug conjugate technology designed to deliver cell-killing agents directly to tumor cells. The largest global oncology biotechnology company based in the Pacific Northwest, we are focused on developing and commercializing a new generation of targeted, empowered antibody-based therapies that have the potential to change the foundation of treatment for people with cancer. Our industry-leading antibody-drug conjugate (ADC) technology combines the specificity of monoclonal antibodies, innovative linker systems, and the power of potent cell-killing agents to treat cancer. Using our proprietary technology, we are able to optimize each ADC to potentially improve outcomes for patients.

OTHER ARTICLES

How Chemical Companies Benefit from the Experience Economy

Article | February 10, 2020

To feel or experience from a business engagement started with customer experience mainly in the consumer products business. Today it has extended to even knowledge industries like the chemical industry where experiencing or feeling can be leveraged to include all stake holders from customers primarily to employees to supply chain people & suppliers and all else. With digital technologies this has become easier than before. The benefits from promoting the ‘feel’ or ‘experience’ emotion could be multifarious for the chemical industry as described in this article.

Read More

Sustainability: A Core Initiative for Collaboration in the Chemical Industry

Article | February 19, 2020

Legislation and pressure from stakeholders are forcing the chemical industry to find efficiencies and urgently seek out ways to reduce environmental impact, such as implementing low-carbon initiatives, maximizing energy and water efficiency and developing new innovative products and processes. Last month’s World Economic Forum added further urgency as shareholders and investment groups added new sustainability criteria to their investment considerations. As the pressure to improve sustainability rises, organizations like SusChem, the European Technology Platform for Sustainable Chemistry, are gaining visibility and traction.

Read More

Setting record straight on testing harm in chemicals

Article | February 13, 2020

The modern world is built on chemicals, be it the medicines we use, or cleaning fluids, crop protection products, or the raw materials for everything from laptops and mobile phones to clothes and furniture. Across all, we have created an entire modern society with chemicals, and, as a result, constantly stretched the size of the world population we can feed, clothe and shelter. Yet, balancing all the gains from the modern chemistry around us against any negative environmental and human impact has been a rising concern, making for ever greater focus on testing and on risk assessment.

Read More

Closing the loop: Real-time measurement of oil in water for process facilities

Article | May 10, 2021

When an oilfield’s reservoir pressure is depleted during primary recovery, additional oil can be recovered by recycling the produced water and injecting it back into the reservoir. Water management is critical for such water and water-alternating-gas (WAG) floods. In its Permian basin operations, Occidental recovers, recycles, and re-injects large volumes of water for its enhanced oil recovery (EOR) operations. With real-time monitoring of oil in water (OiW) delivering reliable and continuous data, Occidental identified a way to optimize the recovery process and is working with NOV to expand the use of OiW monitoring equipment.

Read More

Spotlight

Seattle Genetics

Seattle Genetics is dedicated to improving patient outcomes through advanced antibody-drug conjugate technology designed to deliver cell-killing agents directly to tumor cells. The largest global oncology biotechnology company based in the Pacific Northwest, we are focused on developing and commercializing a new generation of targeted, empowered antibody-based therapies that have the potential to change the foundation of treatment for people with cancer. Our industry-leading antibody-drug conjugate (ADC) technology combines the specificity of monoclonal antibodies, innovative linker systems, and the power of potent cell-killing agents to treat cancer. Using our proprietary technology, we are able to optimize each ADC to potentially improve outcomes for patients.

Events